跳转至内容
Merck
CN

870852C

Avanti

C18:1(Δ9-cis) Carnitine

Avanti Research™ - A Croda Brand

别名:

oleoyl L-carnitine

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C25H47NO4
化学文摘社编号:
13962-05-5
分子量:
425.64
UNSPSC代码:
12352211
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

C18:1(Δ9-cis) Carnitine, Avanti Research™ - A Croda Brand 870852C

方案

>99% (TLC)

表单

liquid

包装

pkg of 1 × 1 mL (870852C-5mg)

制造商/商品名称

Avanti Research™ - A Croda Brand 870852C

浓度

5 mg/mL (870852C-5mg)

脂质类型

bioactive lipids

运输

dry ice

储存温度

−20°C

SMILES字符串

C[N+](C)(C)C[C@H](OC(CCCCCCC/C=C\CCCCCCCC)=O)CC([O-])=O

InChI

1S/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h12-13,23H,5-11,14-22H2,1-4H3/b13-12-

InChI key

IPOLTUVFXFHAHI-SEYXRHQNSA-N

应用

C18:1(Δ9-cis) Carnitine may be used as an internal standard in tandem mass spectrometry (MS/MS) for quantitative measurement of carnitines in plasma sample.

生化/生理作用

C18:1(Δ9-cis) Carnitine, also known as oleoyl L-carnitine, has a potential to inhibit glycine transporter 2 (GLYT2) in a non-competitive manner. It is used as an effective therapeutic for treating pain.

包装

5 mL Clear Glass Sealed Ampule (870852C-5mg)

法律信息

Avanti Research is a trademark of Avanti Polar Lipids, LLC

象形图

Skull and crossbonesHealth hazard
GHS06,GHS08

警示用语：

Danger

危险分类

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

靶器官

Central nervous system, Liver,Kidney

储存分类代码

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 3

闪点(°F)

does not flash

闪点(°C)

does not flash

法规信息

危险化学品
易制毒化学品（2类）
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

J E Carland et al.
British journal of pharmacology, 168(4), 891-902 (2012-09-18)
Concentrations of extracellular glycine in the CNS are regulated by two Na(+)/Cl(-) -dependent glycine transporters, GlyT1 and GlyT2. Selective inhibitors of GlyT1 have been developed for the treatment of schizophrenia, whilst selective inhibitors of GlyT2 are analgesic in animal models
Lawrence C Johnson et al.
Clinical science (London, England : 1979), 132(16), 1765-1777 (2018-06-20)
Advancing age is associated with impairments in numerous physiological systems, leading to an increased risk of chronic disease and disability, and reduced healthspan (the period of high functioning healthy life). The plasma metabolome is thought to reflect changes in the

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持